f-star Biotech

f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. develops therapeutic antibodies and antibody fragments through modular antibody technology. Its modular antibody technology allows the introduction of additional binding sites into...

Founded in 2006
Homepage: http://www.f-star.com/
Total money raised: $45.2M

1230 Gastgebgasse 5-13

Vienna
AUT

Phone: +43 (0)-72055-4215

Updated on Jul 17, 2011
f-star Biotech at CrunchBase

Kevin FitzGerald CEO
Eugen Stermetz CFO
Past

April, 2011

f-star Biotech raised $20.3M in unattributed round from SR One, Atlas Venture, Aescap Venture, Novo Ventures, Merck Serono Ventures, TVM Capital, and MP Healthcare Venture Management

f-star raises â‚¬15M in a New Financing led by SR One

January, 2010

f-star Biotech raised $10.8M in a Series A round from MP Healthcare Venture Management and Merck Serono Ventures

f-star raises â‚¬8m in an Extended Series A Financing co-led by MP Health-care Venture Management and Merck Serono Ventures

November, 2007

f-star Biotech raised $4.1M in a Series A round from Novo A/S

Antibody Engineering Company F-Star Raises EUR 3.0 million in a Second Closing of its Series A Financing Round from Novo A/S

September, 2007

f-star Biotech raised $8.1M in a Series A round from Aescap Venture and Atlas Venture

Antibody Engineering Company F-Star Raises EUR 6.0 million in Series A Financing from Aescap Venture and Atlas Venture

January, 2007

f-star Biotech raised $2M in seed round from Atlas Venture

Antibody-Company F-Star Raises EUR1.5 million in Seed Financing Round From Atlas Venture

2006

f-star Biotech was founded in 2006